Evofem Biosciences Valuation
| EVFMDelisted Stock | USD 0.05 0.0001 0.21% |
Evofem Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Evofem Biosciences from reviewing the firm fundamentals such as Shares Outstanding of 121.22 M, operating margin of (5.41) %, and Shares Owned By Insiders of 0.28 % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Evofem Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Evofem Biosciences is based on 3 months time horizon. Increasing Evofem Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evofem otc stock is determined by what a typical buyer is willing to pay for full or partial control of Evofem Biosciences. Since Evofem Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evofem OTC Stock. However, Evofem Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0479 | Real 0.0455 | Hype 0.05 |
The intrinsic value of Evofem Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Evofem Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Evofem Biosciences helps investors to forecast how Evofem otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evofem Biosciences more accurately as focusing exclusively on Evofem Biosciences' fundamentals will not take into account other important factors: Evofem Biosciences Total Value Analysis
Evofem Biosciences is currently forecasted to have valuation of 112.69 M with market capitalization of 6.41 M, debt of 125.74 M, and cash on hands of 19.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Evofem Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
112.69 M | 6.41 M | 125.74 M | 19.89 M |
Evofem Biosciences Investor Information
The company recorded a loss per share of 19.01. Evofem Biosciences last dividend was issued on the 18th of January 2018. The entity had 1:15 split on the 6th of May 2022. Based on the key indicators related to Evofem Biosciences' liquidity, profitability, solvency, and operating efficiency, Evofem Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Evofem Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Evofem Biosciences has an asset utilization ratio of 19.39 percent. This suggests that the OTC Stock is making $0.19 for each dollar of assets. An increasing asset utilization means that Evofem Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Evofem Biosciences Ownership Allocation
Evofem Biosciences holds a total of 121.22 Million outstanding shares. Roughly 99.15 percent of Evofem Biosciences outstanding shares are held by general public with 0.28 (percent) owned by insiders and only 0.57 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Evofem Biosciences Profitability Analysis
The company reported the previous year's revenue of 8.24 M. Net Loss for the year was (205.19 M) with profit before overhead, payroll, taxes, and interest of 4.19 M.About Evofem Biosciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Evofem Biosciences. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Evofem Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Evofem Biosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Evofem Biosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evofem Biosciences. We calculate exposure to Evofem Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evofem Biosciences's related companies.Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in womens sexual and reproductive health. Evofem Biosciences, Inc. is headquartered in San Diego, California. Evofem Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 119 people.
8 Steps to conduct Evofem Biosciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Evofem Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Evofem Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Evofem Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Evofem Biosciences' revenue streams: Identify Evofem Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Evofem Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Evofem Biosciences' growth potential: Evaluate Evofem Biosciences' management, business model, and growth potential.
- Determine Evofem Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Evofem Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Evofem Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Evofem Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 125.2 M | |
| Retained Earnings | -860.7 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |